ENTENTE Network and the Last Mile of Science

The bottleneck in biotechnology is not always discovery. Sometimes it is the sentence that makes an investor, patient, regulator, or reporter understand why the discovery matters. ENTENTE built a consultancy - and a set of intelligence tools - for that last mile.